Adverse Effects

Latest News

ATR04-484 showed inhibition of both methicillin-sensitive and methicillin-resistant Staphylococcus aureus bacteria strains, which are associated with rash.
Advancing Treatment for EGFR Inhibitor–Associated Dermal Toxicities

July 8th 2025

ATR04-484 showed inhibition of both methicillin-sensitive and methicillin-resistant Staphylococcus aureus bacteria strains, which are associated with rash.

Frailty Assessments Indicate Severe AE Probability in Prostate Cancer
Frailty Assessments Indicate Severe AE Probability in Prostate Cancer

April 28th 2025

Radical Prostatectomy Linked to Lower GU Toxicity in Localized Prostate Cancer
Radical Prostatectomy Linked to Lower GU Toxicity in Localized Prostate Cancer

April 28th 2025

Auditory Attention Decay Noted Post-Treatment in Pediatric Cerebellar Tumors
Auditory Attention Decay Noted Post-Treatment in Pediatric Cerebellar Tumors

April 9th 2025

All patients who received HT-001 in the phase 2a CLEER-001 trial showed significant skin toxicity improvements by 6 weeks.
Topical Gel Significantly Improves EGFR Inhibitor-Related Skin Toxicity

January 11th 2025

Video Interviews
Latest CME Events & Activities

More News